Ryan M Miller

This inventor holds 16 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Histotripsy Systems. Top assignees: Histosonics, Inc., University of Michigan. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan M Miller. Retrieved from https://idiyas.com/inventor/ryan-m-miller-znni7wga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 69(Granted Patents)

Location History:

Ann Arbor, MI (US) (2021 - 2023)
Saline, MI (US) (2024)

Company Filing History:

University of Michigan

patents

Years Active: 2021-2026

Loading Chart...

Areas of Expertise:

Histotripsy

Therapeutic Ultrasound

Graphical User Interface

Treatment Navigation

User Interfaces

Workflows

Color Doppler Feedback

Medical Imaging

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12773186 - Histotripsy systems and methods (2026-10-27),

2. D1142449 - DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE (2026-08-18),

3. 12642994 - Histotripsy systems and methods (2026-06-02),

4. 12642993 - High intensity therapeutic ultrasound (HITU) histotripsy systems, methods and treatment navigation software (2026-06-02),

5. 12599784 - Histotripsy systems and methods (2026-04-14),

6. 12589261 - Histotripsy systems and methods (2026-03-31),

7. 12491384 - Histotripsy systems and methods (2025-12-09),

8. 12491382 - Histotripsy systems and methods (2025-12-09),

9. 12446905 - Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy (2025-10-21),

10. 12420118 - Histotripsy systems and methods (2025-09-23),

11. D1085113 - Display screen or portion thereof with an animated graphical user interface (2025-07-22),

12. D1075797 - Display screen or portion thereof with graphical user interface (2025-05-20),

13. 11980778 - Histotripsy systems and methods (2024-05-14),

14. 11813484 - Histotripsy systems and methods (2023-11-14),

15. 11648424 - Histotripsy systems and methods (2023-05-16),

Title: Innovations in Histotripsy: The Contributions of Ryan M. Miller

Introduction

Ryan M. Miller is an accomplished inventor based in Ann Arbor, Michigan, known for his significant contributions to the field of medical technology. He has been awarded three patents, specifically focusing on advanced histotripsy systems that improve therapeutic procedures for tissue treatment.

Latest Patents

Miller's latest patents revolve around histotripsy therapy systems, which are designed to provide non-invasive and minimally invasive options for therapeutic, diagnostic, and research purposes. His patented systems are optimized for targeted histotripsy applications that excel in various regions and conditions, ensuring that there is minimal or no damage to non-target tissues or structures. This technological advancement marks a critical step forward in medical treatment methodologies.

Career Highlights

Throughout his career, Ryan M. Miller has worked with prestigious organizations, including Histosonics, Inc. and the University of Michigan. His role within these institutions allowed him to develop and refine his innovative systems, making notable contributions to the healthcare industry.

Collaborations

Miller's work has involved collaborations with several professionals in his field, including Jonathan M. Cannata and Alexander P. Duryea. Their collective expertise has helped in advancing the research and development of histotripsy technologies, promoting innovations that enhance patient care and treatment effectiveness.

Conclusion

Ryan M. Miller's contributions to the field of histotripsy exemplify the impact of dedicated inventors on medical technology. With his innovative patents and collaborative efforts, he continues to pave the way for advancements that promise to transform therapeutic practices and improve patient outcomes.

Profile summary based on public USPTO records.